Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Therapeutic De-escalation and miRNA-M371 Biomarker Evaluation Phase II Study for Stage IIa/IIb < 3 cm Seminomas

NCT05529251 is registered in ClinicalTrials.gov with Centre Leon Berard as lead sponsor.

NCT NCT05529251
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05529251 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Therapeutic De-escalation and miRNA-M371 Biomarker Evaluation Phase II Study for Stage IIa/IIb < 3 cm Seminomas
Lead sponsor
Centre Leon Berard
Phase
Phase 2
Overall status
Recruiting
Start date
September 6, 2022
Completion date
May 4, 2032
Enrollment
90 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

seminoma, stage ii